Abstract
Statement of the problem Temporomandibular disorder (TMD) represents a common group of disorders related to the impairment of the temporomandibular joints and the associated neuro-muscular system, which commonly present with features such as pain in the orofacial region, headache, joint sounds, and disturbances in jaw movements. Recently, botulinum toxin type-A (BTX-A) has increasingly been used as an adjuvant treatment for TMD. Purpose of the study This retrospective study aims to evaluate the effectiveness of BTX-A for the management of myogenous TMD and its potential to be included as a first line of treatment. Materials and methods A retrospective search was carried out through the Oral and Maxillofacial Department’s logbook from January 1, 2016, to December 31, 2020. Patients who received BTX-A for the management of myogenous TMD were identified and their hospital electronic records were accessed. Results From January 1, 2016, to December 31, 2020, 60 patients were diagnosed with myogenous TMD and treated conservatively together with intramuscular injections of BTX-A. Forty-five patients (75%) reported improvement in pain levels, of whom 10 (17%) reported complete resolution of pain. Fifteen patients (25%) reported no improvement in pain levels, of whom four (7%) reported transient improvement in pain levels lasting four weeks. A mean improvement of 50% was reported in terms of self-perceived pain levels. No adverse effects from BTX-A treatment were reported. Conclusion Although BTX-A shows great potential to be included as a first line of treatment for myogenous TMD, more high-quality research with larger sample sizes, minimal bias, and longer follow-up periods is needed.
Reference30 articles.
1. Management of TMD: evidence from systematic reviews and meta-analyses;T. List;Journal of Oral Rehabilitation,2010
2. Multidimensional approach to the differences between muscular and articular temporomandibular patients: coping, distress, and pain characteristics;Maria José GaldÓn;Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology,2006
3. Botulinum toxin in the management of temporomandibular disorders: a systematic review;S. Thambar;British Journal of Oral and Maxillofacial Surgery,2020
4. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study;Luca Guarda-Nardini;CRANIO®,2008
5. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique;Luca Guarda-Nardini;CRANIO®,2012